Stocklytics Platform
Asset logo for symbol PHGE
BiomX
PHGE48
$0.87arrow_drop_down0.75%-$0.00
Penny Stock
Asset logo for symbol PHGE
PHGE48

$0.87

arrow_drop_down0.75%

Performance History

Chart placeholder
Key Stats
Open$0.92
Prev. Close$0.89
EPS-3.90
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
Market Cap$16.45M
PE Ratio-
LOWHIGH
Day Range0.86
0.99
52 Week Range0.88
8.55
Ratios
Revenue-
EBITDA Margin %-
EPS-3.90

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

About BiomX (PHGE)

BiomX Inc (PHGE) is a biotechnology company that focuses on developing and commercializing novel treatments for microbiome-related diseases. The company utilizes its proprietary platform to identify and validate proprietary bacterial targets and develop phage therapies to address various diseases. BiomX has a strong pipeline of potential therapeutics for conditions such as inflammatory bowel disease (IBD), colorectal cancer, and primary sclerosing cholangitis (PSC).
The stock price history of BiomX Inc (PHGE) has shown significant volatility in recent years. From its initial public offering (IPO) in 2019, the stock had a relatively stable performance until mid-2020. Since then, the share price has experienced notable fluctuations, which can be attributed to various factors such as clinical trial results, partnership announcements, and market sentiment towards the biotechnology sector.
Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Jonathan Eitan Solomon MBA
Headquarters
Ness Ziona
Employees
54
Exchange
NYSE
add BiomX  to watchlist

Keep an eye on BiomX

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is BiomX 's (PHGE) price per share?

The current price per share for BiomX (PHGE) is $0.88. The stock has seen a price change of -$0.01 recently, indicating a -0.75% change. This reflects the stock's recent market performance and investor sentiment.
help

What is the 52-week high and low for BiomX (PHGE)?

For BiomX (PHGE), the 52-week high is $8.55, which is 871.7% from the current price. The 52-week low is $0.88, the current price is -0.24% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help

Is BiomX (PHGE) a growth stock?

BiomX (PHGE) has shown an average price growth of -4.13% over the past three years. It has received a score of 86 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying BiomX as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help

What is BiomX (PHGE) stock price performance year to date (YTD)?

As of the latest data, BiomX (PHGE) has a year-to-date price change of -68.39%. Over the past month, the stock has experienced a price change of -17.77%. Over the last three months, the change has been -61.41%. Over the past six months, the figure is -73.81%. Looking at a longer horizon, the five-year price change stands at -99.13%.
help

Is BiomX (PHGE) a profitable company?

BiomX (PHGE) has a net income of -$26.17M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 0% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. Operating income is noted at -$27.68M. Furthermore, the EBITDA is -$27.71M.
help

What is the market capitalization of BiomX (PHGE)?

BiomX (PHGE) has a market capitalization of $16.45M. The average daily trading volume is 0.88, indicating the stock's liquidity and investor engagement.

News

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level